Compare BNED & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNED | TOI |
|---|---|---|
| Founded | 1965 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.0M | 327.6M |
| IPO Year | 2015 | N/A |
| Metric | BNED | TOI |
|---|---|---|
| Price | $8.43 | $2.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 246.6K | ★ 1.3M |
| Earning Date | 04-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.47 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,610,170,000.00 | N/A |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $27.09 |
| P/E Ratio | $44.16 | ★ N/A |
| Revenue Growth | ★ 2.75 | N/A |
| 52 Week Low | $5.90 | $0.61 |
| 52 Week High | $12.19 | $4.88 |
| Indicator | BNED | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 46.89 |
| Support Level | $8.23 | $2.37 |
| Resistance Level | $9.67 | $2.97 |
| Average True Range (ATR) | 0.39 | 0.19 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 57.26 | 51.20 |
Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.